Home › Research › Brain tissue and pathology
Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention
Félix Bermejo‐Pareja, Teodoro del Ser. Journal of Clinical Medicine, 2025-10-31
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This narrative review of Alzheimer's disease (AD) history, therapy and prevention shows that its conceptualization has changed three times over 100 years. First, AD was a normative creation by Kraepelin in 1910 of a rare presenile dementia characterized by specific histological features. Second, during the 1970s, American neurologists, driven by sociological changes, merged presenile and senile dementias into an Alzheimer-type dementia with the universally accepted clinicopathological diagnostic criteria of McKhann. By the end of the 20th century, AD was divided into early-onset genetic (1%) and late-onset sporadic (99%) forms. In the 21st century, AD was redefined as a biological entity, using biological and neuroimaging markers of amyloid, tau and neurodegeneration, to better address research and clinical trials. This new nosology has been widely criticized, given the absence of curative therapy, the evidence of mixed pathology in most cases and the decline in the dementia/AD incidence in high-income countries. However, there are currently many drugs against AD in the pipeline; prevention appears as medical and social therapy. In summary, the ancient concept of age-related dementia has evolved into AD normative disorders over 100 years. Nowadays, AD requires a conceptual reassessment, although its medical paradigm remains. Awaiting pharmacological breakthroughs, dementia prevention seems the best practical approach.
What this study adds
Evidence grade: Low
This is a narrative review. It states that many drugs are in the pipeline and that prevention appears as medical and social therapy, but it reports no new treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bermejo‐Pareja, F., & del Ser, T. (2025). Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14217752
Vancouver
Bermejo‐Pareja F, del Ser T. Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention. Journal of Clinical Medicine. 2025. doi:10.3390/jcm14217752. PMID: 41227148.
BibTeX
@article{bermejopareja2025-41227148,
author = {Bermejo‐Pareja, Félix and del Ser, Teodoro},
title = {{Alzheimer Syndrome or Age-Related Dementia—History, Therapy and Prevention}},
journal = {Journal of Clinical Medicine},
year = {2025},
doi = {10.3390/jcm14217752},
pmid = {41227148},
url = {https://doi.org/10.3390/jcm14217752}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- This new nosology has been widely criticized, given the absence of curative therapy, the evidence of mixed pathology in most cases and the decline in the dementia/AD incidence in high-income countries.
- However, there are currently many drugs against AD in the pipeline; prevention appears as medical and social therapy.
- In summary, the ancient concept of age-related dementia has evolved into AD normative disorders over 100 years.
- Nowadays, AD requires a conceptual reassessment, although its medical paradigm remains.
- Awaiting pharmacological breakthroughs, dementia prevention seems the best practical approach.
Why it matters
This narrative review traces how the concept of Alzheimer's disease has changed over 100 years and notes that the current biological definition has been widely criticized given the absence of curative therapy, mixed pathology in most cases and declining dementia incidence in high-income countries. It states that many drugs are in the pipeline and that prevention appears as medical and social therapy, but it reports no new treatment, cure or prevention.
Study details
- Study designnarrative review
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Clinical Medicine) |
| Journal's citation record | 2 / 4 | Journal of Clinical Medicine: journal h-index 188 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | Design recorded as “narrative review”, which our rubric does not rank (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Teodoro del Ser: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Universidad Complutense de Madrid: institution h-index 656 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41227148) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/jcm14217752
- PubMed: 41227148
- Original source →
- Free full text: Journal of Clinical Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 53.
Related studies in Brain tissue and pathology from nearby years
Also in Brain tissue and pathology
124 studies in the library are filed under Brain tissue and pathology with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Brain tissue and pathology hub.